Supply chain visibility and control key to building market share in pharma
Control and visibility are the two most vital aspects of a shipper’s pharma supply chain, ...
© Khunaspix Dreamstime.
The Swiss group said on 2 September that the “extraordinary general meeting of Kuehne + Nagel International AG approves [the] new allocation of available net profit 2019.”
It added:
At today’s Extraordinary General Meeting of Kuehne + Nagel International AG, shareholders overwhelmingly approved the new allocation of available net profit for the business year 2019, which was carried forward by the ordinary Annual General Meeting on May 5, 2020.
As of September 8, 2020, an ordinary dividend of CHF 4.00 gross per share less 35% Swiss withholding tax (i.e. CHF 2.60 net) will be paid out. The remaining profit less the dividend will be carried forward.
The full post can be found here.
Elsewhere, market talk is that management continue to look very closely at their operating cost base, which must come down.
Comment on this article